ORBIMED ADVISORS LLC 13D and 13G filings for Adicet Bio, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-03-21 4:31 pm Unchanged | 2024-03-19 | 13D | Adicet Bio, Inc. ACET | ORBIMED ADVISORS LLC | 9,772,598 11.900% | 0 (Unchanged) | Filing |
| 2024-01-29 4:55 pm Purchase | 2024-01-25 | 13D | Adicet Bio, Inc. ACET | ORBIMED ADVISORS LLC | 9,772,598 12.900% | 3,125,000 (+47.01%) | Filing |
| 2023-06-29 4:30 pm Purchase | 2023-06-27 | 13D | Adicet Bio, Inc. ACET | ORBIMED ADVISORS LLC | 6,647,598 15.500% | 6,647,598 (New Position) | Filing |